ABUS icon

Arbutus Biopharma
ABUS

Overview Fund Activity

24 hedge funds and large institutions have $39.5M invested in Arbutus Biopharma in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.

Holders
24
Holders Change
+6
Holders Change %
+33.33%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
12
Increased
6
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Franklin Resources
1
Franklin Resources
California
$16.1M
2
SM
2
Sabby Management
Florida
$4.14M
3
BBA
3
Baker Bros. Advisors
New York
$3.99M
4
PC
4
PointState Capital
New York
$2.77M
5
AWMDMG
5
Austin W. Marxe & David M. Greenhouse
New York
$1.96M

Top Sellers

1
PA
1
Perceptive Advisors
New York
$0
2
KA
2
Kerrisdale Advisers
Florida
$0
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$5.97M
4
LOM
4
Loeb Offshore Management
New York
$0
5
FANJ
5
Financial Architects (New Jersey)
New Jersey
$0
Name Market Value Shares Shares
Change 		Shares
Change %
KA
26
Kerrisdale Advisers
Florida
– – -90,057 Closed
LOM
27
Loeb Offshore Management
New York
– – -10,000 Closed
FANJ
28
Financial Architects (New Jersey)
New Jersey
– – -9,000 Closed
Barclays
29
Barclays
United Kingdom
– – -400 Closed
Wells Fargo
30
Wells Fargo
California
– – -200 Closed
1
2